Corcept Therapeutics reported $17.42M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
Ani Pharmaceuticals ANIP:US $ 92.54M 9.39M
Ardelyx ARDX:US 4.53M 1.04M
Aurora Cannabis Inc ACB:CN 139.92M 10.02M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Bristol Myers Squibb BMY:US $ 2142M 38M
Canopy Growth Corp WEED:CN C$ 205.51M 1.13M
Corcept Therapeutics CORT:US $ 17.42M 12.34M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Esperion Therapeutics ESPR:US $ 29.23M 6.42M
Lannett LCI:US $ 95.16M 0.28M
Nektar Therapeutics NKTR:US $ 16.97M 1.59M
Novartis NOVN:VX SF 6880M 117M
Pacira Pharmaceuticals PCRX:US $ 100.59M 3.07M
Supernus Pharmaceuticals SUPN:US $ 84.86M 3.94M